Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common stock, $0.08 par value
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
10K
-
Shares change
-
-36.5K
-
Total reported value, excl. options
-
$5.09K
-
Value change
-
-$21.5K
-
Number of sells
-
-4
-
Price
-
$0.50
Significant Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) as of Q4 2024
5 filings reported holding SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value as of Q4 2024.
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10K shares
.
Largest 5 shareholders include BANK OF MONTREAL /CAN/ (10K shares), UBS Group AG (8 shares), Baader Bank Aktiengesellschaft (0 shares), GSA CAPITAL PARTNERS LLP (0 shares), and JPMORGAN CHASE & CO (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.